Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1998-04-16
2000-11-28
Badio, Barbara
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A61K 359, C07C40100
Patent
active
061536059
ABSTRACT:
Compounds of formula (I) ##STR1## as defined by the specification. The compounds are useful in the treatment or prevention of vitamin D dependent disorders, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis, leukemia, osteoporosis, hyperparathyroidism accompanying renal failure, transplant rejection and graft vs. host disease.
REFERENCES:
patent: 5447924 (1995-09-01), Bretting
patent: 5817648 (1998-10-01), Kutner et al.
patent: 5843928 (1998-12-01), Deluca et al.
patent: 5945410 (1999-08-01), Deluca et al.
Grue-Soerensen, et al. Proc. Workshop, Vitamin D, vol. 9, 1994 pp. 75-76.
Barbier Pierre
Bauer Franz
Mohr Peter
Muller Marc
Pirson Wolfgang
Badio Barbara
Hoffman-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Silverman Robert A.
LandOfFree
Arylsecocholadiene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsecocholadiene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsecocholadiene derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726017